Responses by major responses to chemotherapy plus N-CWS (9CR, 11 PR),while in the confrol group, 11 of 18(61. 1%: 4 CR, 7 PR).

• 恶性淋巴瘤中，CR9例，PR11例，有效率为71.；4%25，而对照组中CR4例，PR7例，两者无显著差异。